Alternatives to the Streptozotocin-Diabetic Rodent

Area of Science:

• Neuroscience
• Endocrinology
• Pharmacology

Background:

• Diabetic neuropathy research predominantly uses streptozotocin-induced rodent models of type 1 diabetes.
• Diabetic peripheral neuropathy is a complex condition with multifactorial etiology, including factors beyond insulin deficiency, relevant to obesity and both type 1 and type 2 diabetes.

Purpose of the Study:

• To review the development and application of diverse rodent models for investigating diabetic neuropathy.
• To explore the contribution of non-insulin deficiency factors in the pathogenesis of diabetic neuropathy across different diabetes types and obesity.

Main Methods:

• Review of existing literature on rodent models of diabetic neuropathy.
• Analysis of models investigating factors beyond insulin deficiency in type 1 diabetes, type 2 diabetes, and obesity-associated neuropathy.

Main Results:

• No single animal model fully replicates human diabetic peripheral neuropathy.
• Rodent models are valuable for elucidating disease mechanisms and preclinical treatment screening.

Conclusions:

• Despite challenges, animal models are essential for advancing the understanding of diabetic neuropathy etiology.
• Future therapeutic strategies may require combination approaches and improved early detection methods for successful clinical translation.